ENA0000GenomicsNational Cancer Institutehttps://www.ebi.ac.uk/ena/browser/view/PRJNA331221Homo sapiensFor the Clinical Trials Sequencing Project (CTSP), National Cancer Institute (NCI) will utilize whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing to try to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures that would be important to the hypothesis(es) submitted by the investigators. The samples will be processed and submitted for genomic characterization using pipelines and procedures established within The Cancer Genome Analysis (TCGA) project. Data analysis will be performed as a collaboration between the National Clinical Trials Network (NCTN) Group and its investigators submitting the proposal. The investigators at the NCI-sponsored Genomic Data Analysis... (for more see dbGaP study page.)ENAIntervention Study.human being, human., man0.00.00.00.00.00falseHomo sapiensClinical Trial Sequencing Project (CTSP)2022-05-122016-07-28PRJNA3312219606